Fungal pneumonia in patients with hematologic malignancies: current approach and management

Victor E Mulanovich1, Dimitrios P Kontoyiannis

  • 1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. vmulanov@mdanderson.org

Abstract

Insights

Recent advances in diagnosing and treating fungal pneumonia in hematologic malignancy patients improve outcomes. New diagnostic methods and tailored treatments are key for better patient-specific care.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Mycology

Background:

  • Fungal pneumonia is a common invasive mold infection (IMI) in patients with hematologic malignancies.
  • Epidemiology of IMIs in hematopoietic stem cell transplant recipients is evolving due to changes in treatments and prophylaxis.

Purpose of the Study:

  • To review recent advances in the epidemiology, diagnosis, and treatment of fungal pneumonia in patients with hematologic malignancies.
  • To discuss improvements in patient outcomes related to invasive mold infections.

Main Methods:

  • Review of recent literature on fungal pneumonia in immunocompromised patients.
  • Analysis of diagnostic advancements including PCR, serologic tests, and imaging.
  • Evaluation of treatment strategies, including preemptive and empirical therapies, and new antifungal agents.

Main Results:

  • Improved diagnostic accuracy and timeliness through combined use of PCR, serologic tests, and imaging.
  • Newer triazoles and prompt diagnosis contribute to better patient outcomes.
  • Preemptive therapy is being compared to traditional empirical therapy for febrile neutropenic patients.

Conclusions:

  • Diagnosis and treatment of fungal pneumonia are becoming increasingly personalized.
  • Integration of host factors, novel diagnostics, and pharmacologic considerations is crucial.
  • Institution-specific and patient-specific approaches enhance care for hematologic malignancy patients.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: